Nicole LaBrosse

Insider Reports History

Entity
Individual
Location
11388 Sorrento Valley Road, San Diego, CA
Signature
/s/ James R. Oehler, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nicole LaBrosse:

Stock Role Class Num Shares Value Price $ Report Date Ownership
HALOZYME THERAPEUTICS, INC. SVP, CHIEF FINANCIAL OFFICER Restricted Stock Units 26.8K $966K $36.10 Feb 23, 2024 Direct
HALOZYME THERAPEUTICS, INC. SVP, CHIEF FINANCIAL OFFICER Common Stock 15.5K $840K $54.25 Jul 22, 2024 Direct
HALOZYME THERAPEUTICS, INC. SVP, CHIEF FINANCIAL OFFICER Option to Purchase Common Stock 5K $69.4K $13.87 Jun 28, 2024 Direct
HALOZYME THERAPEUTICS, INC. SVP, CHIEF FINANCIAL OFFICER Option to Purchase Common Stock 0 Jul 22, 2024 Direct

Insider Reports Filed by Nicole LaBrosse

Symbol Company Period Transactions Value $ Form Type Date Filed Role
HALO HALOZYME THERAPEUTICS, INC. Jul 22, 2024 5 -$157K 4 Jul 23, 2024 SVP, CHIEF FINANCIAL OFFICER
HALO HALOZYME THERAPEUTICS, INC. Jun 26, 2024 9 -$883K 4 Jun 28, 2024 SVP, CHIEF FINANCIAL OFFICER
HALO HALOZYME THERAPEUTICS, INC. Feb 23, 2024 2 $0 4 Feb 27, 2024 SVP, CHIEF FINANCIAL OFFICER
HALO HALOZYME THERAPEUTICS, INC. Feb 16, 2024 6 -$202K 4 Feb 20, 2024 SVP, CHIEF FINANCIAL OFFICER
HALO HALOZYME THERAPEUTICS, INC. Feb 15, 2024 3 -$24.6K 4 Feb 16, 2024 SVP, CHIEF FINANCIAL OFFICER
HALO HALOZYME THERAPEUTICS, INC. Feb 10, 2024 3 -$52.4K 4 Feb 13, 2024 SVP, CHIEF FINANCIAL OFFICER
HALO HALOZYME THERAPEUTICS, INC. Feb 16, 2023 5 -$124K 4 Feb 21, 2023 SVP, CHIEF FINANCIAL OFFICER
HALO HALOZYME THERAPEUTICS, INC. Feb 15, 2023 3 -$30.6K 4 Feb 17, 2023 SVP, CHIEF FINANCIAL OFFICER
HALO HALOZYME THERAPEUTICS, INC. Feb 10, 2023 6 -$101K 4 Feb 14, 2023 SVP, CHIEF FINANCIAL OFFICER
HALO HALOZYME THERAPEUTICS, INC. Nov 15, 2022 2 -$269K 4 Nov 16, 2022 SVP, CHIEF FINANCIAL OFFICER
HALO HALOZYME THERAPEUTICS, INC. Feb 15, 2022 5 -$14.9K 4 Feb 17, 2022 SVP, Chief Financial Officer
HALO HALOZYME THERAPEUTICS, INC. Feb 10, 2022 9 -$67.5K 4 Feb 14, 2022 SVP, Chief Financial Officer
HALO HALOZYME THERAPEUTICS, INC. Feb 2, 2022 0 $0 3 Feb 11, 2022 SVP, Chief Financial Officer